DE EN
CeMM Scientific Recess 2019

CeMM Scientific Recess 2019

From February 18-20, 2019, the annual Scientific Recess of CeMM with representatives from each research group and our facilities took place in Waidhofen a.d. Ybbs. Thank you to the organizers Andreas Villunger and Christoph Binder and to all the participants from CeMM and the Adjunct groups, who contributed with their presentations of new ideas and with lively discussions to a successful meeting. The overall topic of the 2019 recess was to…
Ignaz L. Lieben Award for CeMM Adjunct PI Nuno Maulide

Ignaz L. Lieben Award for CeMM Adjunct PI Nuno Maulide

Congratulations to Nuno Maulide, Professor for Organic Synthesis at the University of Vienna, Corresponding Member of the Austrian Academy of Sciences, and CeMM Adjunct Principal Investigator, for receiving the Ignaz L. Lieben Award of the Austrian Academy of Sciences! As a scientist with a broadly documented expertise in state-of-the-art innovations in organic synthesis, and a great talent and dedication for science communication and teaching,…
Finding second hits to knock out leukemia

Finding second hits to knock out leukemia

Targeted drugs are a cornerstone of personalized medicine, yet come with important drawbacks. They restrain disease progression – but rarely eradicate the cancer. Patients therefore need to take the drugs essentially forever, exposing them to severe side effects and incurring high costs for the healthcare system. Combination therapies could potentially overcome these limitations. A study by scientists from CeMM, the Research Center for Molecular…
A catalog of the human kinome in response to genotoxic stress, induced by chemotherapeutic agents

A catalog of the human kinome in response to genotoxic stress, induced by chemotherapeutic agents

An important group of genes that is frequently mutated in cancer consists of kinases, which mediate communication within cells. As enzymes, kinases are promising candidates to target for cancer therapy and as such, by identifying interactions between kinases and chemotherapeutic drugs the treatment for cancer could be improved. A research team, led by CeMM PI Joanna Loizou, together with colleagues from the Francis Crick Institute and King´s…
How cancer becomes transmissible in Tasmanian devils: molecular mechanisms elucidated

How cancer becomes transmissible in Tasmanian devils: molecular mechanisms elucidated

Facial tumors of Tasmanian devils belong to the extremely rare cases of transmissible cancers. Nevertheless, they are highly interesting for biomedical research, as they allow the study of fundamental properties of cancer cells and their interaction with the host´s immune system. Scientists at CeMM, the Vienna University of Veterinary Medicine, the Medical University of Vienna and the LBI for Cancer Research were able to elucidate key molecular…
Season Greetings

Season Greetings

Thank you to our collaborators, partners and friends for all the support and dedication to science in 2018! CeMM wishes you enjoyable holidays, and a successful start into the New Year! 
9th S.M.A.R.T. Lecture held by Professor Wolfgang Lutz

9th S.M.A.R.T. Lecture held by Professor Wolfgang Lutz

Population trends and the global sustainable development goals The 9th S.M.A.R.T. Lecture held by Professor Wolfgang Lutz, Founding Director of the Wittgenstein Centre for Demography and Global Human Capital (IIASA, VID/ÖAW, WU), was a plea for education. Particularly female education not only connects to a decrease of child mortality and to an increase of life expectancy, it proves to be key to the alleviation of poverty. In his talk, Wolfgang…
CeMM position on genome editing in the light of recent reports about gene-edited babies

CeMM position on genome editing in the light of recent reports about gene-edited babies

Following internal discussions at CeMM on human genome editing – prompted by recent reports on the birth of gene-edited babies using CRISPR technology in China – we distance ourselves from human trials performed without adequate ethical approval by the responsible institutions and in violation of both local regulations and the international consensus in the scientific community. CeMM welcomes responsible research on understanding and advancing…
Kaan Boztug receives ERC Consolidator Grant

Kaan Boztug receives ERC Consolidator Grant

Kaan Boztug, Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), is awarded a prestigious Consolidator Grant of the European Research Council (ERC) for research on human immune dysregulation. Kaan Boztug, Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), Adjunct PI at CeMM and Professor of Pediatrics at the Medical University of Vienna and St. Anna Children’s Hospital,…
International PhD Program in Molecular Technologies and Systems Medicine CALL OPEN

International PhD Program in Molecular Technologies and Systems Medicine CALL OPEN

Do you want to work in an environment that promotes free-minded scientific creativity, and translate your findings to impact medical practice and improve healthcare?Are you excited to gain a new understanding of the molecular physiology and pathology of humans?Do you want to join an international group of highly collaborative and successful colleagues that help you achieve your training and research goals?Are you a person who enjoys teamwork…
New mechanism controlling the master cancer regulator uncovered

New mechanism controlling the master cancer regulator uncovered

Who regulates the key regulator? The Superti-Furga laboratory at CeMM reports online in the journal Science about a newly discovered mechanism by which RAS proteins, central to cancer signaling, are regulated in their activity and localization. Of the more than 23,000 genes in the human genome, only a handful assume a very central role in signal transduction and growth regulation. Of these, the three genes encoding RAS proteins are particularly…
Welcome to new CeMM and LBI-RUD Adjunct PIs

Welcome to new CeMM and LBI-RUD Adjunct PIs

We are happy to announce that during Summer/Autumn we had a successful search for new CeMM and LBI-RUD Adjunct Principal Investigators. A warm WELCOME to: Miriam Unterlass (CeMM) - Materials Chemistry, Technical University of ViennaNuno Maulide (CeMM) – Organic Chemistry, University of ViennaAndreas Villunger (CeMM/LBI-RUD) – Division of Developmental Immunology, Medical University of InnsbruckThomas Reiberger (LBI-RUD/CeMM) – Division of…
Basophils - underestimated players in lung development

Basophils - underestimated players in lung development

The adult lung consists of different, highly specialized cell types that are protected by a variety of immune cells. Using advanced single cell sequencing methods, researchers of the Weizmann Institute of Science in Israel, the CeMM and the Medical University in Vienna discovered a hitherto unknown, fundamental role of basophils in the development of macrophages in the lung. The study, published in Cell, could open new clinical strategies to…
New Artwork by Klaus Pamminger at CeMM

New Artwork by Klaus Pamminger at CeMM

We are happy and proud to announce a new piece of art located in the small seminar room at CeMM: Stiegenhaus, 11 Square Albin Cachot, 75013 Paris-13E / RC01-BDJ 2018Balsa wood, lacquer, multi-partapprox. 270 x 520 x 32 cm The artwork is a generous gift from our befriended artist Klaus Pamminger who has already contributed a piece of art to the CeMM Brain Lounge. Until Summer 2018 the wall sculpture was part of the exhibition COLLAGE at the…
CeMM Outing 2018

CeMM Outing 2018

To start the academic year with a community experience CeMM had its yearly Outing on Friday, October 5, 2018. This year´s thematic focus was on traffic and public transport, and built on our previous SMART lecture held by architect and urban design consultant Jan Gehl on “Livable cities for the 21st century”. We were very glad for the opportunity to visit the light rail manufacturing plant of Siemens Mobility GmbH in the 11th district of Vienna…